(Q35906331)

11 August 2017

1 reference

title

Enterococcus faecalis resistant to linezolid: case series and review of the literature (English)

1 reference

11 August 2017

1 reference

Enterococcus faecalis

object named as

Enterococcus faecalis

1 reference

Brian S Burleson

1

1 reference

11 August 2017

David J Ritchie

series ordinal

2

1 reference

11 August 2017

Scott T Micek

series ordinal

3

1 reference

11 August 2017

W Michael Dunne

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

24

1 reference

11 August 2017

issue

9

1 reference

11 August 2017

page(s)

1225-1231

1 reference

Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Treatment options for vancomycin-resistant enterococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Stability of repetitive-sequence PCR patterns with respect to culture age and subculture frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Linezolid-resistant enterococci: report of the first isolates in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Isolation of linezolid-resistant Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Daptomycin: a novel agent for Gram-positive infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Mechanism of action of oritavancin and related glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1225.38086

10.1592/PHCO.24.13.1225.38086

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference